Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Citi
Dow
Johnson and Johnson
Deloitte
Harvard Business School
Farmers Insurance
AstraZeneca
Baxter

Generated: May 25, 2018

DrugPatentWatch Database Preview

FEXOFENADINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Fexofenadine Hydrochloride, and when can generic versions of Fexofenadine Hydrochloride launch?

Fexofenadine Hydrochloride is a drug marketed by Barr, Actavis Mid Atlantic, Dr Reddys Labs Ltd, Mylan, Teva, Aurolife Pharma Llc, Hetero Labs Ltd V, Sciegen Pharms Inc, Sun Pharm Inds, Wockhardt Ltd, Aurobindo Pharma Ltd, Impax Pharms, and Sun Pharma Global. and is included in seventeen NDAs.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
Drug patent expirations by year for FEXOFENADINE HYDROCHLORIDE
Pharmacology for FEXOFENADINE HYDROCHLORIDE
Synonyms for FEXOFENADINE HYDROCHLORIDE
(+-)-p-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidino)butyl)-alpha-methylhydratropic acid hydrochloride
138452-21-8
153439-40-8
2-(4-(1-HYDROXY-4-(4-(HYDROXYDIPHENYLMETHYL)PIPERIDIN-1-YL)BUTYL)PHENYL)-2-METHYLPROPANOIC ACID HCL
2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydr
2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydrochloride
2-(4-(1-HYDROXY-4-[4-(HYDROXY-DIPHENYL-METHYL)-PIPERIDIN-1-YL]-BUTYL)-PHENYL)-2-METHYL-PROPIONIC ACID HYDROCHLORIDE
2-(4-{1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl}-phenyl)-2-methyl-propionic acid; hydrochloride
2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride
2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropans
2-[4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-1-piperidyl]-butyl]phenyl]-2-methyl-propanoicacidhydrochloride
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid hydrochloride
2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid;hydrochloride
2S068B75ZU
4-[(4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid hydrochloride
4-[1-HYDROXY-4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINYL]BUTYL]-ALPHA,ALPHA-DIMETHYL-BENZENEACETIC ACID, HYDROCHLORIDE (1:1)
4-[4-[4-(Hydroxydiphenylmethyl)-1-pieridinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid hydrochloride
4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid hydrochloride
452F218
4CH-009369
AB0011964
AB07499
AC-24745
AC1L1Y6V
AC1Q3E6W
AK-72915
AKOS015907422
Allegra
Allegra (TN)
Allegra Allergy
Allegra Flash
Allegra Hives
Allegra OD
alpha-(4-(1-carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol
Altiva
ANW-43654
BB_SC-4132
Benzeneacetic acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-, hydrochloride
Benzeneacetic acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-, hydrochloride, (+-)-
BIM-0050472.0001
BR-72915
C32H39NO4.HCl
C32H40ClNO4
Carboxyterfenadine hydrochloride
CARBOXYTERFENADINE,TERFENADINECARBOXYLATE
CAS-153439-40-8
CCG-213275
CF0042
CHEBI:5051
CHEMBL1200618
Children's Allegra Allergy
Children's Allegra Hives
CPD000718798
CS-4483
CTK8B4006
D00671
DSSTox_CID_28642
DSSTox_GSID_48716
DSSTox_RID_82912
DTXSID5048716
F0698
Fexofenadine (hydrochloride)
FEXOFENADINE HCL
Fexofenadine HCl, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Fexofenadine hydrochloride (JP17/USAN)
Fexofenadine hydrochloride [USAN:USP]
Fexofenadine hydrochloride, >98% (HPLC)
Fexofenadine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Fexofenadine hydrochloride, United States Pharmacopeia (USP) Reference Standard
FEXOFENADINE(HCL FORM)
fexofenadine(hclform)
FexofenadineHydrochloride
Fexofenidine hydrochloride
FT-0631183
HE181612
HY-B0801A
J-505843
J10191
KB-222041
KS-000011XN
KS-1057
LS-173025
M-016455-O
MDL 16,455A
MDL 16.455
MDL 16455 hydrochloride
MDL 16455A
MDL-16455
MDL-16455A
MFCD00865710
MLS001306422
MLS001332493
MLS001332494
MolPort-003-666-536
NC00724
NCGC00015453-02
NCGC00015453-05
NCGC00015453-08
NCGC00092389-01
NCGC00095906-01
NCGC00095906-02
NSC-758678
NSC758678
Pharmakon1600-01504179
RP17816
RRJFVPUCXDGFJB-UHFFFAOYSA-N
RTR-006346
S-5170
s3208
SAM002700173
SCHEMBL40914
SMR000718798
SPECTRUM1504179
Telfast
TELFAST BD
Terfenadine carboxylate hydrochloride
Terfenidine carboxylate hydrochloride
Tox21_113125
Tox21_113125_1
TR-006346
UNII-2S068B75ZU
Z2210694607

US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sciegen Pharms Inc FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 204507-004 Sep 16, 2015 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Barr FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE fexofenadine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076236-001 Apr 14, 2005 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva FEXOFENADINE HYDROCHLORIDE HIVES fexofenadine hydrochloride TABLET;ORAL 076447-007 Apr 13, 2011 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076447-008 Apr 13, 2011 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Citi
Johnson and Johnson
Mallinckrodt
AstraZeneca
Fish and Richardson
US Department of Justice
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.